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SUMMARY
We describe the largest outbreak of hepatitis B virus infection reported to date in the UK.
Between July 2001 and December 2005, 237 cases were identiﬁed in Avon, South West England.
The likely route of transmission was injecting drug use in 44% (104/237) and heterosexual
intercourse in 30% (71/237) of cases. A case-control study in injectors showed that injecting
crack cocaine [adjusted odds ratio (aOR) 23.8, 95% conﬁdence interval (CI) 3.04–186, P<0.001]
and sharing injecting paraphernalia in the year before diagnosis (aOR 16.67, 95% CI 1.78–100,
P=0.010) were strongly associated with acute hepatitis B. In non-IDUs number of sexual
partners and lack of consistent condom use were high compared to a national sample. We
describe the control measures implemented in response to the outbreak. This outbreak has
highlighted the problems associated with the low uptake from the national hepatitis B vaccination
policy which targets high-risk groups, the diﬃculties of identifying those at risk of acquiring
hepatitis B infection through heterosexual sex, and injecting crack cocaine as a risk factor for
hepatitis B.
Key words : Bloodborne virus transmission, community outbreaks, hepatitis B, infectious disease
epidemiology, injecting drug users (IDUs).
INTRODUCTION
At least 350 million people worldwide are infected
with chronic hepatitis B virus (HBV) infection [1],
despite the availability for the past two decades of a
safe and eﬀective vaccine. The World Health
Organization Global Advisory Group recommends
that all countries integrate HBV vaccine into national
immunization schedules [2]. The UK is a country of
low endemicity for HBV, with between 650 and 750
cases of acute HBV in England and Wales each year
in a population of 61 million. In 2003, injecting drug
use was the single most commonly reported risk as-
sociated with acute HBV infection, accounting for
34% of individuals in England and 27% in Wales.
Injecting drug use is also the most commonly ident-
iﬁed risk factor in UK HBV outbreaks [3]. The UK,
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however, has opted to implement a policy of targeted
vaccination [4]. The success of this strategy depends
on the identiﬁcation and vaccination of risk groups,
including injecting drug users (IDUs) and men who
have sex with men (MSM).
Outbreak setting
Bristol is a city of 523 000 people (estimated from
2001 Census) in the South West of England, with an
estimated 25000 recreational drug users. The number
of problem drug users has recently been estimated to
be about 8500, with 3280–5540 IDUs [5], equivalent
to 1.3–2.2% of the 15–55 years age group in Bristol.
In the South West region as a whole, laboratory
notiﬁcations of acute HBV (HBsAg positive and anti-
HBc IgM positive) between 1990 and 2000 have ﬂuc-
tuated between 30 and 70 cases annually (5–11% of
the total number of reports in England and Wales)
(data from Avon Health Authority, UK, which has
the same surveillance system as other UK local auth-
orities).
From July 2001, the number of reports of acute
HBV infection in the Avon area of South West
England (including Bristol, Bath, North and North
East Somerset, and South Gloucester ; population
1.1 million), started to increase from a background
rate of 16–19 cases per year (from 1998 to 2001). Basic
descriptive data reported by patients diagnosed early
on in the outbreak (methods described in detail
below) showed that there were cases in IDU and
non-IDU populations. An outbreak team was set up
to identify factors within the drug-using population
that put them at risk of HBV infection, and to de-
scribe in detail the proﬁle of those in whom injecting
drug use was not a potential source of exposure.
This study aimed to describe the evolution of a
community outbreak of HBV from July 2001 to
December 2005 and present two studies conducted to
investigate risk factors for acute HBV within IDU
and non-IDU populations.
METHODS
Laboratory methods
The Specialist Virology Centre, Health Protection
Agency South West Regional Virus Laboratory,
Bristol, UK performs all laboratory testing for viral
hepatitis in the Avon Health Authority and all con-
ﬁrmatory testing for the South West of England.
Serum samples from patients with suspected viral
hepatitis were tested for hepatitis A virus (HAV)
(IgM), HBV surface antigen (HBsAg), and hepatitis C
virus (HCV) IgG by enzyme-linked immunoassay
(EIA, Ortho-Clinical Diagnostics, UK). All positive
HBsAg tests were conﬁrmed with a second EIA
(Biokit, UK). They were also tested for HBV core
immunoglobulin M (anti-HBc) and total antibody,
HBVe antigen (HBeAg) and antibody to HBeAg
(anti-HBe) by EIA (Ortho-Clinical Diagnostics).
Deﬁnition of acute HBV cases
Cases of acute HBV were deﬁned as those who were
HBsAg and HBV core (anti-HBc) IgM positive, with
no past history of HBV infection or demonstrated
seroconversion to anti-HBc IgG supported by other
HBV markers [antibody to surface antigen (anti-HBs)
was used in cases where anti-HBc IgG was indeter-
minate], with or without a recent history of discrete
onset of jaundice or other symptoms compatible with
acute infection. The samples had to have been taken
in the Avon area between July 2001 and December
2005. Background data from April 1998 were avail-
able from the Avon Health Authority.
Methods of outbreak investigation
The evolution of the outbreak was described using
data collected from routine investigation of all acute
HBV cases identiﬁed by the Specialist Virology
Centre, which are reported to the Health Protection
Unit in Bristol for follow up. Patients are contacted
by a public health nurse and asked to complete a
telephone questionnaire about potential exposures to
HBV. Data collected from July 2001 onwards were
supplemented by information provided by general
practitioners (GPs) and from case-notes of hospital-
ized cases.
We describe below two studies that address speciﬁc
hypotheses about the spread of the HBV outbreak in
cases who reported injecting drug use as a potential
risk factor and cases who did not report injecting drug
use as a potential risk factor during initial investi-
gations of the community outbreak.
Case-control study in IDUs
We hypothesized that cases would report higher
levels than controls of crack cocaine use [6] and large
numbers of needle-sharing contacts [7], based on risk
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factors reported in the literature. We also investigated
risk factors suggested by local anecdotal reports. We
hypothesized that : cases were more likely than con-
trols to have arrived recently in Bristol ; and that cases
might be more likely than controls to practise fre-
quent injection, especially into the groin and to have
had recent skin infections with breaks in the skin that
could result in mucosal transmission, since admission
of IDUs to the local hospital for skin and soft tissue
infections had increased.
Criteria for participation in the case-control study,
in addition to the case deﬁnition, are given in Table 1.
Cases were identiﬁed retrospectively from those re-
ported by the Specialist Virology Centre from 1
January 2002 to 30 September 2003. Intensive meth-
ods were used to enrol cases. If a case could not be
contacted using addresses found on the Avon Primary
Care Register (National Health Service Connecting
for Health System and Service Delivery System) then
a ﬁeld worker asked drug workers, workers at needle
exchanges, drug users at needle exchanges and ap-
proached drug users on the street to try to identify
and locate them. Cases who agreed to be interviewed
were met at a location of their choice.
Controls were identiﬁed as part of an ongoing
community-based survey in Bristol during autumn
2003 [8]. The enhanced Unlinked Anonymous Preva-
lence Monitoring Programme (UAPMP) was co-
ordinated by the Public Health Laboratory Service
(the Health Protection Agency since April 2003)
and the Centre for Research on Drugs and Health
Behaviour, London School of Hygiene and Tropical
Medicine, London. Field workers attempted to
identify a random community-based sample of IDUs,
who were at risk of acquiring HBV infection from
community settings including the street (i.e. places
where IDUs congregate), mobile needle exchanges,
‘drop-in’ centres, hostels and through indigenous
contact tracers.
All potential participants were asked for verbal
consent to complete a questionnaire, to provide a
ﬁnger-prick blood specimen, and had to have re-
ported drug injection in the 12 months before the
survey. The questionnaire was designed for UAPMP
and questions that addressed hypotheses about the
outbreak were added. Experienced ﬁeld workers
from the community survey team conducted all in-
terviews face-to-face, to overcome possible reading
diﬃculties.
Data management and univariable analysis were
performed using EpiData Analysis (EpiData Associ-
ation, Denmark) to estimate univariable odds ratios
(OR), with 95% conﬁdence intervals (CI) [9]. Stata
(Stata Corporation, USA) was used for multivariable
analyses [10]. An automated stepwise procedure was
used to identify the factors most strongly associated
with acute HBV. All variables for which the P value
wasf0.2 in univariable analysis were entered into the
multivariable model. Variables with a P value >0.1
were removed one at a time. Confounding variables
were deﬁned as variables which, when omitted from
the model, changed the estimated odds ratios of the
variables remaining in the model by o10%. These
variables were retained in the ﬁnal model, together
with all variables for which the P value was f0.1.
In all multivariable models we also controlled for age
and sex. Statistical evidence for interactions was not
examinedbecause of the small number of observations.
Case-series in non-IDUs
We hypothesized that cases would report : multiple
heterosexual partnerships, sexual contact with IDUs
or female commercial sex workers (CSWs), lack of
Table 1. Inclusion and exclusion criteria for case-control study
Cases Controls
Living in Avon Health Authority area Living in Avon Health Authority area
History of injecting drug use in 12 months prior to
ﬁrst positive sample
History of injecting drug use in 12 months prior
to interview
HBsAg and anti-HBC IgM positive No knowledge of past or current HBV infection
No previous positive HBV samples or history of
chronic HBV infection
Excluded if identiﬁed through contact tracing
No participation in any other Unlinked Anonymous
Prevalence Monitoring Programme survey
in 2003/2004
No participation in any other Unlinked Anonymous
Prevalence Monitoring Programme survey
in 2003/2004
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condom use, close contact with IDUs with open
wounds or sores.
We composed a questionnaire to investigate sexual
behavioural risk factors. Where possible, the wording
of questions was taken from the UK National Survey
of Sexual Attitudes and Lifestyles 2000 (NATSAL); a
nationally representative survey of 11 161 individuals
aged 16–44 years [11]. Cases were identiﬁed as above
and did not report injecting drug use in the 12 months
before the diagnostic specimen date during initial in-
vestigations. Individuals with acute HBV infection
diagnosed through contact tracing were excluded. We
could not identify a satisfactory community-based
control population for this study. High-risk sexual
behaviour was thought to be a risk factor but genito-
urinary medicine clinics were not an appropriate
source of controls because very few cases presented to
this setting. Enrolling controls from general practice
for a detailed sexual behaviour interview was not
feasible, based on feedback from local GPs. We
therefore compared questionnaire responses with
those reported by NATSAL for the whole UK popu-
lation. Sexual health advisors at the genitourinary
medicine clinic in Bristol conducted the interviews.
The UAPMP study was approved by the Multi-
centre Research Ethics Committee. Ethical committee
approval was not required for interview of cases as
this was part of an outbreak investigation.
RESULTS
Evolution of the outbreak
From July 2001 to December 2005 (54 months), 237
cases of acute HBV were identiﬁed. Figure 1 shows
the distribution of cases over time. Figure 2 shows
that the number of cases who reported injecting drug
use as a risk factor started to increase from July 2001
and peaked in both IDU and non-IDU groups in
the quarter from July to September 2002. Injecting
drug use was the most likely route of transmission
reported by 44% (104/237) of cases overall (Fig. 3).
Heterosexual intercourse was the second most likely
route of transmission overall with 30% (71/237) of
cases, including 17% (40/237) who reported sexual
intercourse with a partner at high risk of HBV
(IDU, CSW, client of CSW, case of jaundice or
chronic HBV) and high-risk heterosexual behaviour
(o2 new partners in the year before diagnosis) re-
ported by 13% (31/237) of cases. Five per cent
(13/237) of cases reported male homosexual or
bisexual intercourse. In three (1%) cases another
risk factor was identiﬁed (blood transfusion, bloody
ﬁght, community needlestick injury). In 20%
(47/237) of cases no risk factor was reported. Males
made up 71% (168/237) of all cases. The median age
of all cases was 33 years [interquartile range (IQR)
29–41years].
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Fig. 1.Acute hepatitis B notiﬁcations in Avon by sex, 7-month running mean, 2001–2005 (data from Avon Health Authority,
UK).
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Case-control study in IDUs
Of 58 IDU cases identiﬁed during the study period,
contact details were available for 35 cases and 29 were
interviewed during autumn 2003. One person ident-
iﬁed as a case denied injecting drug use in the past
year and was excluded. We identiﬁed 202 potential
controls. Of these, 51% (102/202) of individuals
had laboratory evidence of past HBV infection (anti-
HBc positive) and were excluded. There were 33
women in the study (7 cases, 26 controls). Of these,
85% (28/33) reported exchanging sex for money,
drugs or goods. These 28 women reported a median of
350 partners in the past year (IQR 14–33, range
15–2500).
Table 2 shows univariable associations with acute
HBV. Drug users who had lived in Bristol for o10
years were more likely to have had acute HBV (OR
2.86, 95% CI 1.01–9.38). Injecting crack (with or
without heroin) as the most frequent drug was associ-
ated with being a case (OR 4.07, 95% CI 1.36–12.5),
but smoking crack was not. Injectingo3 times on the
last day they injected was, however, less common in
cases than controls (OR 0.27, 95% CI 0.09–0.72).
Groin injecting and skin infections were not associ-
ated with being a case (OR 1.75, 95% CI 0.68–4.48,
P=0.190; OR 0.75, 95% CI 0.27–2.23, P=0.500,
respectively). Having received o2 doses of HBV
vaccine was less common in cases than controls
(OR 0.20, 95% CI 0.05–0.58, P=0.001). There was
no association between numbers of sexual partners
and acute HBV infection in IDUs. One male IDU in
the control group reported sex with male partners.
After adjustment, the factors most strongly associ-
ated with acute HBV infection were crack injection
[adjusted OR (aOR) 23.8, 95% CI 3.04–186,
P<0.001] and reporting having shared needles or
syringes in the last year (aOR 16.67, 95%CI 1.78–100,
P=0.01) (Table 3). There was some evidence that
having lived in Bristol foro10 years remained associ-
ated with acute HBV (aOR 7.62, 95% CI 0.75–77.5,
P=0.060). The odds of having acute HBV were lower
in those who had receivedo2 doses of vaccine against
HBV than those receiving one or no doses (aOR 0.23,
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Fig. 2. Distribution of risk factors for acute HBV over time.
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Fig. 3. Distribution of risk factors for acute HBV,
2001–2005 (n=237).
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95% CI 0.04–1.21, P=0.070), although conﬁdence
intervals in the adjusted analyses were wide.
Case-series in non-IDUs
Of 77 acute HBV cases during the study period who
did not initially report injecting drug use, 30 were in-
terviewed. Two cases were excluded from analyses of
sexual behaviour; one reported injecting drug use and
one had never had sexual intercourse, leaving 22 men
and six women. The mean age of men was 50 years
(range 21–73 years) and for women it was 35 years
(range 26–50 years). Most of these cases had regular
jobs (21/28, 75%) and lived in rented or their
own accommodation (22/28, 79%). Of all cases, 82%
(23/28) had had eithero2 new sexual partners in the
year before HBV diagnosis (11 cases) or had had sex
with a high-risk partner (IDU, female CSW,MSM, or
a jaundiced partner ; 12 cases). We did not ﬁnd any
cases who reported close contact with an IDU with
open wounds or sores.
Table 4 shows the comparison of selected demo-
graphic and sexual behavioural characteristics in male
cases of acute HBV and participants in NATSAL
[12]. Of HBV cases, 36% were divorced or widowed,
compared to 4.4% in NATSAL. There appeared to
be diﬀerences in sexual behaviour between male HBV
cases in Bristol and participants in NATSAL with
higher numbers of new partnerships, percentage of
concurrent partnerships and percentage having had
male sex partners, and a lower percentage of con-
sistent condom use. In six female HBV cases, none
Table 2. Univariable analysis of associations with acute HBV infection in injecting drug users
Variable
Cases
N=28,
n (%)
Controls
N=100,
n (%)
Crude
OR 95% CI P value
Demographic characteristics
Time lived in Bristol, years o10 vs.<10 22 (79) 56 (56) 2.86 (1.01–9.38) 0.030
Length of time injecting, years o4 vs.<4 21 (75) 77 (77) 0.90 (0.31–2.82) 0.800
Living in Bristol since starting to inject Yes vs. no 23 (82) 54 (54) 3.88 (1.3–14.1) 0.010
Ever been in prison Yes vs. no 17 (61) 72 (72) 0.60 (0.23–1.61) 0.300
Homeless, at least 180 days Yes vs. no 14 (50) 34 (34) 1.93 (0.76–4.94) 0.120
Injection behaviours
Ever cleaned needles or syringes
before using them
Yes vs. no 23 (82) 81 (81) 1.08 (0.34–4.10) 0.900
Times injected with last needle o3 vs.<3 2 (7) 12 (12) 0.57 (0.06–2.80) 0.700
Times injected, last day injected o3 vs.<3 7 (25) 56 (56) 0.27 (0.09–0.72) 0.004
Injected with needles/syringes used
by someone else, past year
Yes vs. no 11 (39) 14 (14) 3.84 (1.36–11.1) 0.003
Groin injecting, past year Yes vs. no 13 (46) 33 (33) 1.75 (0.68, 4.48) 0.190
Crack use, ever Yes vs. no 24 (86) 77 (77) 1.79 (0.53–7.80) 0.300
Smoking crack, past year Yes vs. no 17 (61) 74 (74) 0.55 (0.21–1.47) 0.240
Most frequently injected drug Crack/crack+
heroin vs. other
12 (43) 12 (12) 4.07 (1.36–12.5) 0.004
Needlestick with a used needle Yes vs. no 8 (29) 38 (38) 0.66 (0.23–1.74) 0.400
Clinical characteristics
Erythema, abscess, wound sepsis,
DVT at injury site, past year
Yes vs. no 20 (71) 77 (77) 0.75 (0.27–2.23) 0.500
Hepatitis C, patient report Yes vs. no 12 (43) 18 (18) 3.38 (1.23–9.22) 0.010
Hepatitis C, laboratory result Pos vs. neg 14 (50) 44 (44) 1.27 (0.50–3.21) 0.600
Preventive behaviours
Used needle exchange, past year Yes vs. no 15 (54) 85 (85) 0.21 (0.07–0.57) <0.001
Hepatitis B vaccine doses o2 vs.<2 5 (18) 53 (53) 0.20 (0.05–0.58) 0.001
Sexual behaviours
Male sex partners, past year o2 vs.<2 2 (7) 17 (17) 0.38 (0.04–1.77) 0.240
Female sex partners, past year o2 vs.<2 10 (36) 19 (19) 2.35 (0.83–6.46) 0.060
Total sex partners, past year o2 vs.<2 12 (43) 36 (36) 0.75 (0.30–1.95) 0.500
OR, Odds ratio ; CI, conﬁdence interval ; DVT, deep vein thrombosis.
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reported selling sex for money, goods or drugs. The
mean number of new sex partners in the past year
in women was 1.1 [standard deviation (S.D.)=1.4]
compared to mean 0.38 (S.D.=1.2) in NATSAL. No
women with HBV reported consistent condom use,
compared to 18.0% (95% CI 16.8–19.3) of female
respondents in NATSAL. One woman with HBV had
a concurrent partnership.
Of the 22 males recruited to this study, 15 (68%)
cases were aged>35 years. A subgroup of six of these
men were living alone (single or divorced) and were
economically independent (regular job, lived in own
Table 3. Multivariable analysis of factors associated with acute HBV infection in injecting drug users
Variable
Crude Adjusted
P valueOR 95% CI OR 95% CI
Demographic characteristics
Time lived in Bristol, years o10 vs.<10 2.86 (1.01–9.38) 7.62 (0.75–77.5) 0.060
Homeless, at least 180 days Yes vs. no 1.93 (0.76–4.94) 1.86 (0.46–7.50) 0.400
Injecting behaviours
Times injected, last day injected o3 vs.<3 0.27 (0.09–0.72) 0.09 (0.01–0.66) 0.010
Injected with needles/syringes used
by someone else, past year
Yes vs. no 3.84 (1.36, 11.1) 16.67 (1.78–100) 0.010
Groin injecting, past year Yes vs. no 1.75 (0.68–4.48) 2.98 (0.65–13.7) 0.150
Most frequently injected drug Crack/crack+
heroin vs. other
4.07 (1.36–12.5) 23.8 (3.04–186) <0.001
Sexual behaviours
Total sex partners, past year o2 vs.<2 0.75 (0.30–1.95) 0.51 (0.12–2.16) 0.400
Preventive behaviours
Hepatitis B vaccine doses, n o2 vs.<2 0.20 (0.05–0.58) 0.23 (0.04–1.21) 0.070
Used needle exchange, past year Yes vs. no 0.21 (0.07–0.57) 0.33 (0.07–1.67) 0.180
OR, Odds ratio ; CI, conﬁdence interval.
Table 4. Comparisons between Bristol study and men aged 16–44 years in UK National Survey of Sexual Attitudes
and Lifestyles 2000 (NATSAL)
Acute HBV cases, Bristol (n=22)
NATSAL
No. % (95% CI)* % (95% CI)
Marital status#
Single 7 31 39.3
Cohabiting/married 6 27 56.3
Separated/divorced/widowed 8 36 4.4
Sexual behaviour$
New sexual partners, past year,
mean (standard deviation)
18 3.5 (4.3) 0.84 (3.5)
Concurrent partnerships, past year 12 55 (32.2–75.6) 14.6 (13.4–16.0)
Paid for sex, past 5 years 3 13.6 (2.9–34.9) 4.3 (3.7–5.0)
Consistent condom use· 0 0 (0.0–15.4) 24.4 (22.8–26.1)
Homosexual partners, past 5 years 3 13.6 (2.9–34.9) 1.5 (1.2–1.9)
* Results displayed as % (95% conﬁdence interval ; CI) unless otherwise stated.
# Percentages from NATSAL based on weighted base (n=4762; total unweighted n=5679) ; marital status 95% CI not
reported.
$ Measures from NATSAL restricted to respondents who had one or more new partners in the year before interview.
· Condom use on all occasions in the last 4 weeks.
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accommodation). This group reported multiple sexual
partners, but did not report paying for sex.
Control measures
Attempts to control the outbreak addressed three
main areas: vaccination, risk reduction and edu-
cation. The main thrust of the response was to in-
crease vaccination in groups who had been shown to
be at high risk of acquiring infection, namely IDUs,
female CSWs and the homeless population in Bristol.
Vaccination of the homeless and female CSWs started
after October 2003. Vaccination of prisoners, which
pre-dated the outbreak, was continued. Funding was
made available to organizations providing services
to these high-risk groups to enable increased accessi-
bility and availability of HBV vaccine. Risk reduction
was the second facet of the response. Funding was
provided to ensure needle exchanges could increase
their coverage by increasing working hours, the work
of a mobile clinic was supported and accessibility to
needles at exchanges was improved. Finally mechan-
isms to improve the awareness of the infection in
high-risk groups were implemented. Leaﬂets were
provided for injectors, notices in public toilets and
information was provided in the local genitourinary
medicine clinics. No speciﬁc primary preventive mea-
sures were directed towards male heterosexuals with
high levels of risk behaviour because there was no way
of identifying this group. The numbers of immediate
sexual and close household contacts identiﬁed and
vaccinated were not well documented.
DISCUSSION
This study describes a community outbreak of HBV
with 237 identiﬁed cases diagnosed over 54 months.
Themajority of cases weremen and themean age of all
cases was 35 years. The most likely routes of HBV
transmission were injecting drug use (44% of cases)
and heterosexual intercourse (30% of cases). In IDUs,
injecting crack cocaine and having shared injection
paraphernalia in the past year were associated with
acute HBV infection in multivariable analyses. Cases
were also somewhat more likely than controls to have
lived in Bristol for o10 years and somewhat less
likely to have been vaccinated against HBV. In male
cases who did not use injection drugs, numbers of re-
cent sexual partners, the percentage with concurrent
sexual partnerships, and the proportion reporting
sex between men appeared high in comparison to
participants in a nationally representative survey.
The main strength of this outbreak investigation
was our attempt to investigate risk factors both in
IDUs and non-IDUs. In the case-control study, con-
trols were enrolled from the same community from
which the cases came, and about four controls per
case took part. The study population therefore in-
cluded individuals sampled directly from an urban
community of IDUs in England. We believe this to be
the ﬁrst use of this methodology; in previous com-
munity-based HBV outbreaks, controls have been
enrolled from vaccination clinics [13] or outbreak
clinics [14], which might result in bias.
The main limitations to the study relate to the
power and timing of interviews. Cases among IDUs
were identiﬁed retrospectively and were not inter-
viewed until the outbreak had been underway for
some time. Responses might have been inﬂuenced by
more recent behaviour, particularly injection behav-
iours, and these behaviours might have been modiﬁed
by the experience of having had acute HBV. This
might explain why more frequent injection, which
was assessed at the most recent episode of injection,
was more common in controls than cases, while
sharing of injection equipment assessed over the past
year was more common in cases than controls. The
method of recruiting controls might also have in-
troduced bias. Our method over-selects injectors
who may be engaged in greater injecting risk and this
may have diluted the comparisons. Future studies
may employ respondent-driven sampling methods
to reduce this possible source of bias [5]. A further
limitation was that, in non-IDUs, we intended to
conduct a case-control study but we could not identify
an appropriate control group. The participants of
NATSAL provide a population-based comparison
but we did not conduct any formal statistical tests
so any risk factors identiﬁed are only suggestive of
an association. For both studies, the diﬃculties in
locating and enrolling cases limited the sample size, so
the studies lacked statistical power to detect moderate
associations and associations in multivariable analy-
ses. For example, the odds of having received at least
two doses of HBV vaccine were about 80% lower
in cases than controls in both univariable and multi-
variable analyses. The conﬁdence intervals around
the adjusted odds ratios, however, become much
wider when other variables were included in the
model, so the results are compatible with a chance
ﬁnding.
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We believe this to be the largest reported outbreak
of HBV infection in the UK to date, with the most
detailed investigation of heterosexual sexual behav-
iours in cases. A search of Medline and EMBASE
databases from 1972 to the end of 2007 produced
946 citations, from which 18 articles describing
25 community-based HBV outbreaks in developed
countries were identiﬁed [3]. The previously published
community-based HBV outbreaks in the UK reported
3–119 cases [15–20]. Injecting drug use was reported
to be the most common route of transmission in all
these reported studies, except one report of three cases
[16]. In two studies of small outbreaks (both 14 cases)
the route of transmission was not reported [16]. In
Aberdeen, 119 cases were identiﬁed, of which 48%
reported injecting drug use and 27% heterosexual sex
as the likely route of transmission [20]. Heterosexual
behaviours were, however, not investigated. In
Stockport 51 cases were identiﬁed, 39% reported in-
jecting drug use and 10% heterosexual sex, the latter
identiﬁed only through contact with a case [18]. In
Inverclyde, in 87% of 92 cases reporting injecting
drug use, 3% were infected through heterosexual
contact with a case [21]. Our results are also consistent
with the ﬁndings of previous studies in non-outbreak
settings, where multiple partners, duration of sexual
activity, or history of another sexually transmitted
infection have been associated with an increased risk
of HBV transmission [22–25]. MSM are a group with
a higher prevalence of HBV than the general popu-
lation. While there were more MSM in the group of
non-IDUs compared to NATSAL, they were not
over-represented in this outbreak (5% of all cases)
compared to routine surveillance in the UK (7–20%
of cases reported from 1990 to 1993) [26]. Thus the
proportion of MSM was indeed higher in NATSAL,
but this was consistent with the proportion of HBV
cases nationally.
Our investigations conﬁrmed some of our hypoth-
eses and refuted others. In IDUs we found that in-
jecting crack cocaine, but not smoking it, was
associated with acute HBV. We did not ﬁnd crack
cocaine injection reported in any other published
HBV outbreak although smoking crack is linked to
behaviours that increase the risk of other bloodborne
viruses and sexually transmitted infections [6, 27, 28].
There was no evidence that intimate contact with
broken skin resulting from abscesses or groin injec-
tion sites might have contributed to HBV spread in
this outbreak, even though an increase in hospital
admissions due to cellulitis and abscesses had been
observed during the outbreak. Contrary to our hy-
pothesis, we found some evidence that long-term
resident IDUs in Bristol were more likely than recent
arrivals to be cases. We also identiﬁed high levels of
HBV and risky injection behaviour. Of all IDUs in-
terviewed in our case-control study, 82% reported
ever sharing, a ﬁgure more than twice the nationally
reported data [29] and half of the potential controls
were found to be ineligible because they had already
been infected by HBV at the time of recruitment
(51% of controls with anti-HBc). Taken together, the
ﬁndings of large numbers of susceptible IDUs who
became infected and high levels of naturally acquired
HBV suggest that a large proportion of IDUs in
this population had not been vaccinated over a long
period of time.
This large HBV outbreak in Bristol appeared to
aﬀect both IDUs and non-IDUs simultaneously. In
non-IDUs, men aged >35 years, who were economi-
cally independent and lived alone appeared to be a
group at high risk of acquiring acute HBV through
heterosexual intercourse, with high reported levels of
concurrent sexual partnerships and inconsistent con-
dom use. We did not ﬁnd these characteristics re-
ported in other published outbreaks. Contrary to
our hypotheses, we did not ﬁnd high levels of sexual
contact with IDUs or female CSWs. Of the male non-
IDUs that were interviewed, only 14% reported hav-
ing paid for sex. It is possible that we did not elicit this
information, but we think it unlikely because special-
ist sexual health advisors conducted the interviews. It
is also possible that those who acquired HBV through
paid sex with female IDUs were not interviewed. This
is also unlikely because the major reason for exclusion
was being unable to locate cases, not refusal to take
part. The older, single, widowed or divorced men in
the cases might be involved in social networks that
include women with social or sexual links to IDUs.
The notion of older men exchanging goods, housing
or meals in exchange for sex with much younger
women has been discussed in HIV transmission
studies in Africa [30–32], but not so much is known
about this behaviour in the UK. Although, only a
quarter of female IDUs with acute HBV reported ex-
changing sex for drugs, money or other goods, they
reported large numbers of sex partners and might act
as a bridge to their clients. The importance of this type
of networking in the spread of bloodborne viruses has
been described previously [33].
This outbreak investigation has implications for
future prevention and research. We found evidence
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for high levels of ongoing risky injection behaviour
and low levels of vaccination in long-term IDUs resi-
dent in Bristol. This suggests that the current targeted
vaccination policy did not adequately reach IDUs at
the highest risk of HBV infection. Future targeted
preventive activities should ensure high coverage and
completion of HBV vaccination in all identiﬁed IDUs
and their sexual and needle-sharing contacts. The risk
of HBV and other bloodborne viruses through crack
cocaine injection should now be stressed. Prevention
of spread through vaccination might have been hin-
dered by ongoing transmission to heterosexual men
who could not be easily identiﬁed. This suggests that
health promotion messages about the risk of sexual
transmission of HBV and the protection aﬀorded by
correct condom use need to reach the general popu-
lation, in whom there are groups with high levels of
risky sexual behaviour. The beneﬁts of universal HBV
vaccination should be reconsidered. This outbreak
highlighted the problems associated with a targeted
vaccination policy, the diﬃculties of identifying those
at risk of acquiring hepatitis B infection through het-
erosexual sex, and injecting crack cocaine as a risk
factor for hepatitis B.
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